• BIVDA members area

Members' Press Releases

From the monthly archives: February, 2015

We are pleased to present below all posts archived in 'February, 2015'. If you still can't find what you are looking for, try using the search box.

New four-way collaboration aims to improve clinical decision-making in the treatment of colon cancer

EKF Diagnostics

Greenville, South Carolina – 25th February 2015 – EKF Diagnostics subsidiary,Selah Genomics, has announced a major, four-way collaboration with Greenville Health System (GHS, South Carolina), DecisionQ Corporation (Virginia), and BD (Becton Dickinson and Company, New Jersey). Expected to last 18 months, the collaboration aims to unite classic clinical annotations with proprietary next generation sequencing (NGS) technology and artificial intelligence-based decision support algorithms in order to improve clinical decision support in the treatment of colon cancer patients. 

Read the rest of entry »

EKF introduces new diabetic biomarker test – The Stanbio Chemistry GSP LiquiColor® Assay

EFK Diagnostics

Cardiff, UK – 19th February 2015 – EKF Diagnostics, the global diagnostics company, announces that it has introduced a new diabetic biomarker test that provides a 2-3 week indicator of average blood glucose. The Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor® test closes the information gap between daily blood glucose testing and the 2-3 month HbA1c reading. T

Read the rest of entry »

Siemens Healthcare partners with UK’s leading medical supplier in primary carE

Siemens

Siemens Healthcare have partnered with Williams Medical Supplies to bring innovation to point of care testing in primary care. Williams, part of the DCC Vital group of companies, is a leading provider of medical equipment and services to the UK healthcare market. The partnership of core company values and responsible business practice presents a robust and dependable of fering to GPs, nurses and other healthcare professionals.

Read the rest of entry »

FABPulous BV closes Series B Funding; Begins commercial activities with rapid 5-minute point-of-care IVD for H-FABP

FABPulous

The funds will allow the commercialization of the patented and CE-marked H-FABP True Rapid Test ® for exclusion of acute myocardial infarction (AMI) in risk stratification of patients at primary care and emergency medicine.

Read the rest of entry »

Randox Puts Health in the Frontline as Winner In Prestigious European Business Awards

Randox

Leading clinical diagnostics company Randox is delighted to have been selected as a ‘Ruban D’Honneur’ winner for imports/exports in the prestigious European Business Awards 2014/15.

Read the rest of entry »

NEW £20 BLOOD TEST A BREAKTHROUGH IN THE DIAGNOSIS OF BOWEL CANCER

Randox

British and Irish scientists are developing a new £20 blood test for bowel cancer, which could save thousands of lives by spotting the disease at the earliest possible opportunity. The simple check will pick up on antibodies in the blood, produced as the body reacts to the onset of bowel cancer.

Read the rest of entry »

Proteome Sciences extends its reach through collaboration with MedBiomix Partners

Proteome Sciences

Cobham, Surrey; 3rd Feb 2015. MedBiomix Partners SAS and Proteome Sciences Ltd are proud to announce they enter into a collaborative network alliance, whose goal is to provide healthcare professionals with advanced data-driven solutions to integrate and make better use of protein expression data that will significantly improve the life and disease conditions of their patients.

Read the rest of entry »

Archive